| Archive | |
| |
| 16 October 2007, Volume 97, Number 8 | |
| |
 | |
| Clinical Studies | back to top |
| |
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer W Schippinger, H Samonigg, R Schaberl-Moser, R Greil, R Thödtmann, J Tschmelitsch, M Jagoditsch, G G Steger, R Jakesz, F Herbst, F Hofbauer, H Rabl, P Wohlmuth, M Gnant & J Thaler for the Austrian Breast & Colorectal Cancer Study Group | |
| Abstract | Full Article | PDF |
1021 |
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study P Österlund, T Ruotsalainen, R Korpela, M Saxelin, A Ollus, P Valta, M Kouri, I Elomaa & H Joensuu | |
| Abstract | Full Article | PDF |
1028 |
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases C Barone, G Nuzzo, A Cassano, M Basso, G Schinzari, F Giuliante, E D'Argento, N Trigila, A Astone & C Pozzo | |
| Abstract | Full Article | PDF |
1035 |
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer T Gamucci, A M D'Ottavio, E Magnolfi, M Barduagni, A Vaccaro, I Sperduti, L Moscetti, F Belli & L Meliffi | |
| Abstract | Full Article | PDF |
1040 |
Are ipsilateral breast tumour invasive recurrences in young (  40 years) women more aggressive than their primary tumours?B Sigal-Zafrani, M A Bollet, G Antoni, A Savignoni, A Vincent-Salomon, J-Y Pierga, R Salmon, X Sastre-Garau & A Fourquet | |
| Abstract | Full Article | PDF |
1046 |
High incidence of silent venous thromboembolism before treatment in ovarian cancer T Satoh, A Oki, K Uno, M Sakurai, H Ochi, S Okada, R Minami, K Matsumoto, Y O Tanaka, H Tsunoda, S Homma & H Yoshikawa | |
| Abstract | Full Article | PDF |
1053 |
Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers T Ota, N Takeshima, T Tabata, K Hasumi & K Takizawa | |
| Abstract | Full Article | PDF |
1058 |
Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory P Wright, A Smith, K Roberts, P Selby & G Velikova | |
| Abstract | Full Article | PDF |
1063 |
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules K M Li, L P Rivory & S J Clarke | |
| Abstract | Full Article | PDF |
1071 |
| |
| Translational Therapeutics | back to top |
| |
Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1 D J A de Groot, M van der Deen, T K P Le, A Regeling, S de Jong & E G E de Vries | |
| Abstract | Full Article | PDF |
1077 |
The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study A M E Bruynzeel, H W M Niessen, J G F Bronzwaer, J J M van der Hoeven, J Berkhof, A Bast, W J F van der Vijgh & C J van Groeningen | |
| Abstract | Full Article | PDF |
1084 |
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells A V Timoshenko, S Rastogi & P K Lala | |
| Abstract | Full Article | PDF |
1090 |
Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells R S Hamamura, J H Ohyashiki, R Kurashina, C Kobayashi, Y Zhang, T Takaku & K Ohyashiki | |
| Abstract | Full Article | PDF | Supplementary Information |
1099 |
| |
| Molecular Diagnostics | back to top |
| |
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer H Kayed, X Jiang, S Keleg, R Jesnowski, T Giese, M R Berger, I Esposito, M Löhr, H Friess & J Kleeff | |
| Abstract | Full Article | PDF |
1106 |
Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines E M Hurt, S B Thomas, B Peng & W L Farrar | |
| Abstract | Full Article | PDF | Supplementary Information |
1116 |
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications H Gakiopoulou, P Korkolopoulou, G Levidou, I Thymara, A Saetta, C Piperi, N Givalos, I Vassilopoulos, K Ventouri, A Tsenga, A Bamias, M-A Dimopoulos, E Agapitos & E Patsouris | |
| Abstract | Full Article | PDF |
1124 |
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer B S Nedergaard, M Ladekarl, H F Thomsen, J R Nyengaard & K Nielsen | |
| Abstract | Full Article | PDF |
1135 |
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients M Frattini, P Saletti, E Romagnani, V Martin, F Molinari, M Ghisletta, A Camponovo, L L Etienne, F Cavalli & L Mazzucchelli | |
| Abstract | Full Article | PDF |
1139 |
C4.4A as a candidate marker in the diagnosis of colorectal cancer C Paret, D Hildebrand, J Weitz, A Kopp-Schneider, A Kuhn, A Beer, R Hautmann & M Zöller | |
| Abstract | Full Article | PDF |
1146 |
| |
| Genetics and Genomics | back to top |
| |
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy M Varna, H Soliman, J-P Feugeas, E Turpin, D Chapelin, L Legrès, L-F Plassa, A de Roquancourt, M Espié, J-L Misset, A Janin, H de Thé & P Bertheau | |
| Abstract | Full Article | PDF |
1157 |
Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis S Van Laere, I Van der Auwera, G Van den Eynden, P Van Hummelen, P van Dam, E Van Marck, P B Vermeulen & L Dirix | |
| Abstract | Full Article | PDF |
1165 |
TGFBR1*6A and Int7G24A variants of transforming growth factor-  receptor 1 in Swedish familial and sporadic breast cancerB Song, S Margolin, J Skoglund, X Zhou, J Rantala, S Picelli, B Werelius & A Lindblom | |
| Abstract | Full Article | PDF |
1175 |
| |
| Letters to the Editor | back to top |
| |
Optimum duration of breast cancer follow-up: a continuing controversy L Maraqa & M Lansdown | |
| Abstract | Full Article | PDF |
1180 |
Reply: Optimum duration of breast cancer follow-up: a continuing controversy D A Montgomery & J M Dixon | |
| Abstract | Full Article | PDF |
1182 |
Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer? W Vogel & H Surowy | |
| Abstract | Full Article | PDF |
1184 |
Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer? S A Narod | |
| Abstract | Full Article | PDF |
1187 |
| |
| Corrigendum | back to top |
| |
GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours J Shamash, T Powles, W Ansell, D Berney, J Stebbing, K Mutsvangwa, P Wilson, S Asterling, S Liu, P Wyatt, S P Joel & R T D Oliver | |
| Abstract | Full Article | PDF |
1188 |
| In this issue | |
| ||
 | Clinical Studies | |
| Translational Therapeutics | |
| Molecular Diagnostics | |
| Genetics and Genomics | |
| Letters to the Editor | |
| Corrigendum | |
| ||
| ||
| ||
 | Preceding issue | |
 | Next issue | |
| ||
| ||
| ||
|
| ||
| ||
 | ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2007 Cancer Research UK | ||
| |||
| Privacy Policy | |||